471 related articles for article (PubMed ID: 28460895)
1. Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction.
Kyhl K; Lønborg J; Hartmann B; Kissow H; Poulsen SS; Ali HE; Kjær A; Dela F; Engstrøm T; Treiman M
Peptides; 2017 Jul; 93():1-12. PubMed ID: 28460895
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
3. Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy.
Zheng RH; Zhang WW; Ji YN; Bai XJ; Yan CP; Wang J; Bai F; Zhao ZQ
Eur J Pharmacol; 2020 Sep; 883():173318. PubMed ID: 32621911
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
McLean BA; Wong CK; Kabir MG; Drucker DJ
Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice.
Huang DD; Huang HF; Yang Q; Chen XQ
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4648-4656. PubMed ID: 30058704
[TBL] [Abstract][Full Text] [Related]
6. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
7. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.
Reichert K; Pereira do Carmo HR; Galluce Torina A; Diógenes de Carvalho D; Carvalho Sposito A; de Souza Vilarinho KA; da Mota Silveira-Filho L; Martins de Oliveira PP; Petrucci O
PLoS One; 2016; 11(11):e0166845. PubMed ID: 27880844
[TBL] [Abstract][Full Text] [Related]
9. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
Zhang Y; Elsik M; Edgley AJ; Cox AJ; Kompa AR; Wang B; Tan CY; Khong FL; Stapleton DI; Zammit S; Williams SJ; Gilbert RE; Krum H; Kelly DJ
Int J Cardiol; 2013 Sep; 168(2):1174-85. PubMed ID: 23219315
[TBL] [Abstract][Full Text] [Related]
10. Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Nozue T; Yamada M; Tsunoda T; Katoh H; Ito S; Iwaki T; Michishita I
Heart Vessels; 2016 Aug; 31(8):1239-46. PubMed ID: 26293570
[TBL] [Abstract][Full Text] [Related]
11. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
[TBL] [Abstract][Full Text] [Related]
12. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure.
Liu Q; Anderson C; Broyde A; Polizzi C; Fernandez R; Baron A; Parkes DG
Cardiovasc Diabetol; 2010 Nov; 9():76. PubMed ID: 21080957
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Gao Y; Gao J; Chen C; Wang H; Guo J; Wu R
Planta Med; 2015 May; 81(7):568-77. PubMed ID: 25905591
[TBL] [Abstract][Full Text] [Related]
16. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.
Miyauchi T; Fujimori A; Maeda S; Iemitsu M; Sakai S; Shikama H; Tanabe T; Matsuda M; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S64-7. PubMed ID: 15838361
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin octapeptide reduces myocardial fibrosis and improves cardiac remodeling in post myocardial infarction rats.
Wang C; Zhang C; Wu D; Guo L; Zhao F; Lv J; Fu L
Int J Biochem Cell Biol; 2020 Aug; 125():105793. PubMed ID: 32554056
[TBL] [Abstract][Full Text] [Related]
19. CO inhalation at dose corresponding to tobacco smoke worsens cardiac remodeling after experimental myocardial infarction in rats.
Mirza A; Eder V; Rochefort GY; Hyvelin JM; Machet MC; Fauchier L; Bonnet P
Toxicol Sci; 2005 Jun; 85(2):976-82. PubMed ID: 15746005
[TBL] [Abstract][Full Text] [Related]
20. Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B Pathway.
Ma RF; Chen G; Li HZ; Zhang Y; Liu YM; He HQ; Liu CY; Xie ZC; Zhang ZP; Wang J
Chin J Integr Med; 2020 Dec; 26(12):897-904. PubMed ID: 33259022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
